Operating

Change in AR

Biogen Change in AR remained flat by 0.0% to -$25.68M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 53.8%, from -$55.58M to -$25.68M. Over 2 years (FY 2022 to FY 2025), Change in AR shows a downward trend with a -32.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

A decrease is generally positive as it indicates faster collection of cash from customers.

Detailed definition

This measures the change in the amount of money owed to the company by customers for goods or services delivered on cred...

Peer comparison

Standard metric for all companies; peers in medical devices monitor this closely to manage working capital cycles.

Metric ID: change_in_accounts_receivable

Historical Data

15 periods
 Q2 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value-$174.30M-$167.00M$87.50M$0.00$42.20M$93.90M-$77.20M-$55.58M-$55.58M-$55.58M-$55.58M-$25.68M-$25.68M-$25.68M-$25.68M
QoQ Change+4.2%+152.4%-100.0%+122.5%-182.2%+28.0%+0.0%+0.0%+0.0%+53.8%+0.0%+0.0%+0.0%
YoY Change+100.0%+156.2%-188.2%+28.0%+53.8%+53.8%+53.8%+53.8%
Range-$174.30M$93.90M
CAGR-42.1%
Avg YoY Growth+38.9%
Median YoY Growth+53.8%
Current Streak8 quarters growth

Frequently Asked Questions

What is Biogen's change in ar?
Biogen (BIIB) reported change in ar of -$25.68M in Q4 2025.
How has Biogen's change in ar changed year-over-year?
Biogen's change in ar increased by 53.8% year-over-year, from -$55.58M to -$25.68M.
What is the long-term trend for Biogen's change in ar?
Over 2 years (2022 to 2025), Biogen's change in ar has grown at a -32.2% compound annual growth rate (CAGR), from $223.60M to -$102.70M.
What does change in ar mean?
The change in money owed to the company by customers for past sales.